Molecularly-targeted therapy of gastric cancer

被引：0
|
作者：
Jeziorski, Krzysztof G. [1 ]
机构：
[1] Inst Marii Sklodowskiej Curie Warszawie, Ctr Onkol, Klinika Nowotworow Ukladu Pokarmowego, Ul Roentgena 5, PL-02781 Warsaw, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2011年 / 7卷 / 05期
关键词：
gastric cancer; targeted therapy; trastuzumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Gastric cancer is a heterogeneous malignancy with expression of many molecular factors. Trastuzumab is the first biologic drug (targeted therapy) that has shown benefits in terms of increased median overall survival. Trastuzumab in combination with chemotherapy is indicated in metastatic gastric or gastrooesophageal junction cancer in patients with no prior exposure to systemic anticancer therapy for disseminated disease and with HER2 protein overexpression (score of IHC 3+) regardless of HER2 gene copy number and with expression of 2+ combined with HER2 gene amplification, although clinical benefits in this group are much less evident.
引用
收藏
页码：258 / 263
页数：6
相关论文
共 50 条
  • [31] Targeted Therapy for Gastric Cancer
    Elizabeth C. Smyth
    David Cunningham
    Current Treatment Options in Oncology, 2012, 13 : 377 - 389
  • [32] Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques - the Usefulness in the Qualification of Cancer Patients for Molecularly-Targeted Therapies
    Nicos, Marcin
    Wojas-Krawczyk, Kamila
    Krawczyk, Pawel
    Milanowski, Janusz
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 24 (04): : 715 - 723
  • [33] Metal complexes as molecularly-targeted agents against protein-protein interactions
    Zhong, Hai-Jing
    Liu, Li-Juan
    Chan, Daniel Shiu-Hin
    Ma, Dik-Lung
    Leung, Chung-Hang
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2014, 19 : S760 - S761
  • [34] Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer
    Liu, H.
    Lu, J.
    Hua, Y.
    Zhang, P.
    Liang, Z.
    Ruan, L.
    Lian, C.
    Shi, H.
    Chen, K.
    Tu, Z.
    CELL DEATH & DISEASE, 2015, 6 : e1595 - e1595
  • [35] Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer
    H Liu
    J Lu
    Y Hua
    P Zhang
    Z Liang
    L Ruan
    C Lian
    H Shi
    K Chen
    Z Tu
    Cell Death & Disease, 2015, 6 : e1595 - e1595
  • [36] OncoloGIST, BioloGIST, RadioloGIST: the big impact on the field of oncology of a molecularly-targeted therapy designed to treat a rare disease
    Demetri, GD
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (14) : 1976 - 1977
  • [37] Molecularly Targeted Therapies for Gastric Cancer. State of the Art
    Reddavid, Rossella
    Dagatti, Simona
    Franco, Caterina
    Puca, Lucia
    Tomatis, Mariano
    Corso, Simona
    Giordano, Silvia
    Degiuli, Maurizio
    CANCERS, 2021, 13 (16)
  • [38] DETECTION OF PRIMARY AND SECONDARY BRAIN TUMOURS USING MOLECULARLY-TARGETED MAGNETIC RESONANCE IMAGING
    Serres, S.
    Kirkman, M.
    de Pennington, N.
    Bristow, C.
    Sibson, N. R.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 : 385 - 386
  • [39] RB status governs differential sensitivity to cytotoxic and molecularly-targeted therapeutic agents
    Stengel, Kristy R.
    Dean, Jeffry L.
    Seeley, Sarah L.
    Mayhew, Christopher N.
    Knudsen, Erik S.
    CELL CYCLE, 2008, 7 (08) : 1095 - 1103
  • [40] Combination therapy with molecularly targeted agents in lung cancer
    Okamoto, Isamu
    ANNALS OF ONCOLOGY, 2017, 28
12345